MRVI
Maravai Lifesciences Holdings
$6.69
−$0.07 (−1.04%)Jul 27, 2026
Key metrics
The numbers that frame MRVI today
- Market cap
- $1.73B
- P/E (TTM)
- -16.5
- EV / FCF
- -35.3
- Gross margin
- 29.3%
- EV / Sales
- 8.9
- ROIC
- -14.7%
- Div yield
- 0%
- Debt / equity
- 1.3
- 52wk Low
- $1.99
- 52wk High
- $7.44
Growth
Revenue and earnings trend for MRVI
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MRVI
Is Maravai Lifesciences Holdings a good buy?
Yes. Maravai Lifesciences Holdings has excellent momentum, and it outweighs the weak quality here. Growth looks excellent, which supports the long-term business case. We think Maravai Lifesciences Holdings is selling at a high price, which cuts against the buy case.
What is the market capitalization of MRVI?
Maravai Lifesciences Holdings's market capitalization is $1.73B.
What is the P/E ratio for MRVI stock?
Maravai Lifesciences Holdings's current P/E ratio is -16.5.
What is the 52-week high for MRVI stock?
The 52-week high for Maravai Lifesciences Holdings is $7.44. The current close of $6.69 is 10.1% below that high.
What is the 52-week low for MRVI stock?
The 52-week low for Maravai Lifesciences Holdings is $1.99. The current close of $6.69 is 236.2% above that low.
Does MRVI stock pay dividends?
Maravai Lifesciences Holdings does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MRVI?
Maravai Lifesciences Holdings's Debt / Equity ratio is 1.28.